Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer

SIMPLE SUMMARY: The advent of immuno-oncology (IO) agents, particularly immune checkpoint inhibitors (ICIs), has changed the treatment landscape of non-small cell lung cancer (NSCLC). We performed a retro-prospective study to describe the patients’ outcomes prior to and after the local regulatory ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Danesi, Valentina, Massa, Ilaria, Foca, Flavia, Delmonte, Angelo, Crinò, Lucio, Bronte, Giuseppe, Ragonesi, Maria, Maltoni, Roberta, Manunta, Silvia, Cravero, Paola, Andrikou, Kalliopi, Priano, Ilaria, Balzi, William, Gentili, Nicola, Burke, Thomas, Altini, Mattia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497168/
https://www.ncbi.nlm.nih.gov/pubmed/36139641
http://dx.doi.org/10.3390/cancers14184481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497168/
https://www.ncbi.nlm.nih.gov/pubmed/36139641
http://dx.doi.org/10.3390/cancers14184481

Ejemplares similares